Ten-Year Follow-Up of Women at High Risk for Familial Breast and Ovarian Cancer in Otago and Southland, New Zealand
- PMID: 38285763
- PMCID: PMC10911741
- DOI: 10.31557/APJCP.2024.25.1.3
Ten-Year Follow-Up of Women at High Risk for Familial Breast and Ovarian Cancer in Otago and Southland, New Zealand
Abstract
Background: Care for families affected by Familial Breast and Ovarian Cancer (FBOC) is challenging as a broad range of professions and specialties are involved. The aim was to review management and outcomes for a cohort of women at high risk for familial breast and ovarian cancer.
Methods: Ten-year retrospective follow-up study of individuals in Southern New Zealand assessed by Genetic Health Service New Zealand to be high risk for FBOC and without a personal cancer diagnosis at time of consultation.
Results: Twenty women were identified; twelve underwent genetic testing, and a pathogenic BRCA variant was identified in eleven. Eight women had no testing, as no index case was available. Guidelines had been fully adhered to in 55% of women, regardless of BRCA status. Six did not undergo appropriate breast surveillance. To date, seven of the 11 patients who tested positive for a pathogenic BRCA variant (64%) had risk-reducing surgeries. Two women were diagnosed with breast cancer on surveillance imaging; none were diagnosed with ovarian cancer. Four women were lost to follow-up, one of whom subsequently presented with a symptomatic breast cancer.
Conclusions: To our knowledge, this is the first study providing long-term data for FBOC in New Zealand. Overall, guidelines were followed satisfactorily, but some women did not receive appropriate surveillance or referrals. An integrated interdisciplinary long-term care provision model in New Zealand might help to address gaps in FBOC surveillance and management.
Keywords: Hereditary Cancer Syndromes; New Zealand; Practice Guidelines as Topic; Prevention; breast cancer.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures

Similar articles
-
Patterns of referral and uptake of BReast CAncer (BRCA) gene testing of eligible women with ovarian cancer in New Zealand.N Z Med J. 2019 Feb 22;132(1490):26-35. N Z Med J. 2019. PMID: 30789886
-
BRCA genetic testing of individuals from families with low prevalence of cancer: experiences of carriers and implications for population screening.Genet Med. 2012 Jul;14(7):688-94. doi: 10.1038/gim.2012.31. Genet Med. 2012. PMID: 22481128
-
Trends in BRCA Test Utilization in an Integrated Health System, 2005-2015.J Natl Cancer Inst. 2019 Aug 1;111(8):795-802. doi: 10.1093/jnci/djz008. J Natl Cancer Inst. 2019. PMID: 30753636 Free PMC article.
-
Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care.Breast Cancer Res Treat. 2016 Dec;160(3):393-410. doi: 10.1007/s10549-016-4003-9. Epub 2016 Oct 12. Breast Cancer Res Treat. 2016. PMID: 27734215 Review.
-
[Clinical and molecular diagnosis of inherited breast-ovarian cancer].J Gynecol Obstet Biol Reprod (Paris). 2003 Apr;32(2):101-19. J Gynecol Obstet Biol Reprod (Paris). 2003. PMID: 12717301 Review. French.
References
-
- Tewhatuora webite. [(accessed 18.11.2023)]. https://tewhatuora.Shinyapps.Io/cancer-web-tool/ ,(accessed 18.
-
- Eviqwebsite. [[cited 2020 jun 12]]. Available from: Www.Eviq.Org.Au.
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical